Hot Investor Mandate: VC Firm Dedicated to Investing in Therapeutics, Devices, Diagnostics, and Digital Health Technologies Related to Women’s Health

30 Jul

A venture capital firm based in the USA is focused on women’s health and is looking to invest in early-stage companies that develop related technologies. The firm seeks to engage in seed to series A financing rounds and the typical allocation size is up to 1 million USD. The firm is open to both leading and co-investing and is likely to seek a board seat. The firm will consider opportunities across the U.S and is looking to make up to 5 new investments in the next 12 months.

The firm will consider therapeutics, diagnostics, medical devices and digital health as long as the technologies are related to women’s health. The firm is focused on conditions that “affect only women, affect mostly women, and are worse in women”. Within the above categories, the firm will consider all subsectors and indications, including obstetrics and gynecology, cardiology, neurology, infectious diseases, and orphan drugs. The firm is flexible about the phase of development and will consider companies that are relatively early. In general, the firm will consider therapeutics companies that are pre-clinical stages with strong early data and device and diagnostics companies that are in early models of development.

The firm does not have specific requirement for company’s management team. The firm is likely to take a board seat in its portfolio companies and act as an active investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: